Newsroom

The Wall Street Journal: Marco Rubio Latest to Speak Out on Prescription Drug Prices

U.S. Senator Marco Rubio (R-Fla.) became the latest presidential candidate to speak out on prescription drug prices, saying that some pharmaceutical companies are engaging in “pure profiteering” and that high prices threaten to “bankrupt our system.”

Read more

POLITICO: Rubio blasts drug company ‘profiteering’

Republican presidential contender Marco Rubio blasted pharmaceutical company “profiteering” on high-cost prescription drugs during a campaign stop this week – a sign that drug prices are becoming a lightning rod for both parties in the election.

Read more

PRESS STATEMENT: Report: Prescription Drug Spending Tops Year-Over-Year Price Growth for Major Health Categories

Report: Prescription Drug Spending Tops Year-Over-Year Price Growth for Major Health Categories A new report from the Altarum Institute found that from August 2014 to August […]

Read more

Staggering Price Tags Continue to Threaten Patient Access

Exorbitant price tags associated with breakthrough treatments illustrate the broader challenges ahead for the U.S. health care system if excessive drug pricing is not addressed head on.

Read more